Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 845.00
-2.00 (-0.24%)
Aug 27, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.33 billion as of August 26, 2026. Its market cap has decreased by -50.81% in one year.
Market Cap
4.33B
Enterprise Value
3.79B
Revenue
4.69B
Ranking
n/a
PE Ratio
33.82
Stock Price
845.00
ChartMarket Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.33B, a decrease of -63.57%. That is a compound annual growth rate of -35.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 4.33B | -43.12% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Soiken Holdings | 5.86B |
| Chordia Therapeutics | 5.64B |
| Cyfuse Biomedical K.K. | 5.59B |
| D. Western Therapeutics Institute | 5.12B |
| J-Pharma | 5.11B |
| TMS Co., Ltd. | 4.98B |
| Ribomic | 4.69B |
| Transgenic Group | 4.20B |